Everolimus for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC)
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2019.1632289
Abstract: ABSTRACT Introduction: PDAC is a lethal malignancy with a clear unmet need; almost all patients fail 1st, 2nd, and 3rd line multi-agent cytotoxic chemotherapy. The mammalian target of rapamycin (mTOR) has been identified as a… read more here.
Keywords: pdac; treatment advanced; advanced pancreatic; pancreatic ductal ... See more keywords
UPLC-MS based integrated plasma proteomic and metabolomic profiling of TSC-RAML and its relationship with everolimus treatment
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Molecular Biosciences"
DOI: 10.3389/fmolb.2023.1000248
Abstract: Aim: To profile the plasma proteomics and metabolomics of patients with renal cysts, sporadic angiomyolipoma (S-AML) and tuberous sclerosis complex related angiomyolipoma (TSC-RAML) before and after everolimus treatment, and to find potential diagnostic and prognostic… read more here.
Keywords: tsc raml; raml; everolimus treatment; uplc based ... See more keywords
Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus Treatment
Sign Up to like & getrecommendations! Published in 2022 at "Genes"
DOI: 10.3390/genes13101763
Abstract: This real-world cohort analysis assessed the efficacy of alpelisib and endocrine treatment (ET) combinations in a post-everolimus setting. Thirteen women who started alpelisib and ET at standard doses between 2018 and 2022 for advanced breast… read more here.
Keywords: post everolimus; advanced breast; everolimus treatment; breast cancer ... See more keywords
Erratum: Cost-effectiveness of everolimus for the treatment of advanced neuroendocrine tumours of gastrointestinal or lung origin in Canada.
Sign Up to like & getrecommendations! Published in 2018 at "Current oncology"
DOI: 10.3747/co.25.4233
Abstract: [This corrects the article on p. 32 in vol. 25, PMID: 29507481.]. read more here.
Keywords: advanced neuroendocrine; everolimus treatment; treatment advanced; effectiveness everolimus ... See more keywords
Benefit of everolimus in treatment of an intrahepatic cholangiocarcinoma patient with a PIK3CA mutation
Sign Up to like & getrecommendations! Published in 2017 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v23.i23.4311
Abstract: Intrahepatic cholangiocarcinoma (ICC) is a relatively rare form of liver cancer with a poor prognosis. The therapeutic options for patients with advanced ICC are limited and usually ineffective. There is currently no approved targeted therapy… read more here.
Keywords: treatment; intrahepatic cholangiocarcinoma; pik3ca mutation; everolimus treatment ... See more keywords